Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era
- Bellmunt, J.
- Esteban, E.
- Del Muro, X.G.
- Sepúlveda, J.M.
- Maroto, P.
- Gallardo, E.
- Del Alba, A.G.
- Etxaniz, O.
- Guix, M.
- Larriba, J.L.G.
- Arranz, J.A.
- Redrado, M.
- Calvo, A.
ISSN: 2588-9311
Datum der Publikation: 2021
Ausgabe: 4
Nummer: 3
Seiten: 502-505
Art: Artikel